Skip to content
About
Menu Toggle
History of J-Star Research
Menu Toggle
Facilities
Chemical Information Library
Resources
Careers
Menu Toggle
Welcome to our Employment section
Diversity and Inclusion
CA Job Applicant Notice
CA Employee Notice
Contract R&D
Menu Toggle
Process Chemistry R&D
Menu Toggle
Synthetic Route Design
Catalysis & Enabling Technology
High-Throughput Experimentation (HTE)
High Pressure Chemistry Capabilities
Continuous Flow Capabilities
Statistics & Design of Experiments (DoE)
Computational Chemistry Capabilities
PAT & Reaction Kinetics
Analytical R&D and Quality Control
Menu Toggle
Method Development & Forced Degradation
Method Validation & Verification
Reference Standard Certification
Impurity Isolation & Structural Elucidation
Genotoxic Impurities
ICH Stability Studies
Center for Pharma Crystallization
Menu Toggle
Solid Form Screen & Studies
Menu Toggle
Single Crystal Structure Elucidation
Crystallization Process Development
Pre-Formulation Evaluations
Particle Engineering & Co-Processing
Drug Product Development
Menu Toggle
Phase 1 Clinical Supply and Support Services
Phase 2 & 3 Drug Product Development
Technology Demonstration & Feasibility
cGMP & Special Capabilities
Menu Toggle
cGMP Intermediate & API Production
Menu Toggle
cGMP Quality Assurance
Method Validation & Verification
Reference Standard Certification
ICH Stability Studies
Genotoxic Impurities
Special Capabilities
Menu Toggle
Controlled Substances (DEA Schedule II-V)
Potent & HPAPI Compound Development
News & Events
Menu Toggle
Company News
Tradeshows & Conferences
Contact
Contact
Main Menu
About
Menu Toggle
History of J-Star Research
Menu Toggle
Facilities
Chemical Information Library
Resources
Careers
Menu Toggle
Welcome to our Employment section
Diversity and Inclusion
CA Job Applicant Notice
CA Employee Notice
Contract R&D
Menu Toggle
Process Chemistry R&D
Menu Toggle
Synthetic Route Design
Catalysis & Enabling Technology
High-Throughput Experimentation (HTE)
High Pressure Chemistry Capabilities
Continuous Flow Capabilities
Statistics & Design of Experiments (DoE)
Computational Chemistry Capabilities
PAT & Reaction Kinetics
Analytical R&D and Quality Control
Menu Toggle
Method Development & Forced Degradation
Method Validation & Verification
Reference Standard Certification
Impurity Isolation & Structural Elucidation
Genotoxic Impurities
ICH Stability Studies
Center for Pharma Crystallization
Menu Toggle
Solid Form Screen & Studies
Menu Toggle
Single Crystal Structure Elucidation
Crystallization Process Development
Pre-Formulation Evaluations
Particle Engineering & Co-Processing
Drug Product Development
Menu Toggle
Phase 1 Clinical Supply and Support Services
Phase 2 & 3 Drug Product Development
Technology Demonstration & Feasibility
cGMP & Special Capabilities
Menu Toggle
cGMP Intermediate & API Production
Menu Toggle
cGMP Quality Assurance
Method Validation & Verification
Reference Standard Certification
ICH Stability Studies
Genotoxic Impurities
Special Capabilities
Menu Toggle
Controlled Substances (DEA Schedule II-V)
Potent & HPAPI Compound Development
News & Events
Menu Toggle
Company News
Tradeshows & Conferences
Porton Reports Strong Half-Year Results
Home
»
Porton Reports Strong Half-Year Results
Porton Reports Strong Half-Year Results
August 16, 2021
|
News & Events
